Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS Pilot)

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-20

Study Completion Date

2024-05-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall goal of this study is to evaluate the feasibility of a remotely delivered CHAMPS intervention for people living with HIV (PLWH) in a randomized controlled trial. The proposed trial is scientifically significant in representing a principled and systematic effort to test the efficacy of a combined community health worker (CHW) and smartphone intervention linked to a smart pill box for antiretroviral (ART) adherence in PLWH in the United States (US). Guided by a rigorous theoretical model of supportive accountability and building on preliminary work, this intervention has the potential to enable PLWH to self-manage their ART regimens while CHW monitor their ART adherence in real-time ultimately leading to viral suppression and ART adherence.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Community Health Worker And MHealth to ImProve Viral Suppression

NCT04562649

HIV/AIDS

COMPLETED NA

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

NCT06472206

HIV/AIDS

RECRUITING NA

Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management

NCT01510340

HIV

COMPLETED PHASE3

mVIP (Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV)

NCT02897141

HIV (Human Immunodeficiency Virus)

COMPLETED NA

The Wise App Trial for Improving Health Outcomes in PLWH

NCT03205982

HIV/AIDS

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Persons living with HIV (PLWH) now achieve a near-normal life expectancy due to antiretroviral therapy (ART) which has transformed HIV from a terminal diagnosis to a manageable chronic condition. Despite widespread availability of ART in the United States (US), many of the country's approximate 1.1 million PLWH are not fully benefitting from ART due to poor adherence. These suboptimal HIV health outcomes occur at a time when clinicians have limited time and the US healthcare system remains fragmented, further exacerbating the challenges inherent in the lives of underserved, marginalized groups, such as PLWH. Therefore, the development and evaluation of interventions using a cadre of community health workers (CHW) holds promise for addressing these challenges in the US. This study addresses limitations in current research on CHW interventions to improve viral suppression and ART adherence. The ubiquitous nature of mHealth technologies in daily life creates opportunities for health behavior management tools that were not previously possible and has the potential to address many of the healthcare needs of PLWH. The investigators propose to build on strong preliminary data to strengthen a community health worker (CHW) intervention using an existing mHealth approach, and provide further information regarding the successful wide-scale implementation of this combination intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV/AIDS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention or CHAMPS

Wise App that delivers medication adherence reminders and community health worker sessions

Group Type EXPERIMENTAL

Wise App with medication adherence reminders

Intervention Type DEVICE

The Intervention group will receive the Wise App that delivers medication adherence reminders.

CHW Sessions

Intervention Type BEHAVIORAL

The Intervention group will complete sessions with a community health worker (CHW).

Control

Standard of care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wise App with medication adherence reminders

The Intervention group will receive the Wise App that delivers medication adherence reminders.

Intervention Type DEVICE

CHW Sessions

The Intervention group will complete sessions with a community health worker (CHW).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Able to speak, read, and write in English or Spanish;
2. Aged ≥18 years;
3. Willing to provide a valid form of identification for verification;
4. Willing to participate in any assigned arm of the intervention;
5. Having been diagnosed with HIV ≥6 months ago;
6. Have an HIV-1 RNA level \>200 copies/mL as verified by provision of medical records, or have a detectable load of \>500 copies/mL, as measured by dried blood spot (DBS) sample kits, or report either not being virally suppressed in the past 12 months or being virally unsuppressed in the past 12 months;
7. Own a smartphone;
8. Ability and willingness to provide informed consent for study participation and consent for access to medical records; and
9. Live in the United States

Exclusion Criteria

1. Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment;
2. Terminal illness with life expectancy \<3 months;
3. Planning to move out of the country in the next 3months.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No